Theodore G Liou

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi Priorities for lung transplantation among patients with cystic fibrosis
    Theodore G Liou
    JAMA 287:1523-4; author reply 1524-5. 2002
  2. ncbi Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis
    Theodore G Liou
    Department of Medicine, School of Medicine, University of Utah, Salt Lake City, Utah, USA
    PLoS ONE 7:e42748. 2012
  3. ncbi Measurement of lung volumes
    Theodore G Liou
    Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Clin Rev Allergy Immunol 37:153-8. 2009
  4. ncbi Spirometry
    Theodore G Liou
    Division of Respiratory, Critical Care, and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Clin Rev Allergy Immunol 37:137-52. 2009
  5. ncbi Pediatric lung transplantation for cystic fibrosis
    Theodore G Liou
    Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA
    Transplantation 86:636-7. 2008
  6. ncbi Lung transplantation for cystic fibrosis
    Theodore G Liou
    Department of Internal Medicine, University of Utah, Salt Lake City, Utah 84132, USA
    Curr Opin Pulm Med 12:459-63. 2006
  7. ncbi Lung transplantation and survival in children with cystic fibrosis
    Theodore G Liou
    Department of Internal Medicine, University of Utah, Salt Lake City, USA
    N Engl J Med 357:2143-52. 2007
  8. ncbi Use of lung transplantation survival models to refine patient selection in cystic fibrosis
    Theodore G Liou
    Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Am J Respir Crit Care Med 171:1053-9. 2005
  9. ncbi Year-to-year changes in lung function in individuals with cystic fibrosis
    Theodore G Liou
    University of Utah, 26 North 1900 East, Salt Lake City, UT 84132 4701, USA
    J Cyst Fibros 9:250-6. 2010
  10. ncbi Selection of patients with cystic fibrosis for lung transplantation
    Theodore G Liou
    Intermountain Cystic Fibrosis Center, Department of Internal Medicine, Division of Respiratory Critical Care and Occupational Pulmonary Medicine, University of Utah, Salt Lake City 84132, USA
    Curr Opin Pulm Med 8:535-41. 2002

Collaborators

Detail Information

Publications20

  1. ncbi Priorities for lung transplantation among patients with cystic fibrosis
    Theodore G Liou
    JAMA 287:1523-4; author reply 1524-5. 2002
  2. ncbi Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis
    Theodore G Liou
    Department of Medicine, School of Medicine, University of Utah, Salt Lake City, Utah, USA
    PLoS ONE 7:e42748. 2012
    ..These biomarkers are potential CF reporting tools and treatment targets for slowing long-term progression and reducing short-term severity...
  3. ncbi Measurement of lung volumes
    Theodore G Liou
    Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Clin Rev Allergy Immunol 37:153-8. 2009
    ..Patients with mixed restrictive and obstructive disease may have spirometry results that are difficult to interpret, and it is in these patients that lung volume measurements may be especially helpful...
  4. ncbi Spirometry
    Theodore G Liou
    Division of Respiratory, Critical Care, and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Clin Rev Allergy Immunol 37:137-52. 2009
    ..This paper reviews basic concepts, testing procedures, and interpretation of a single set of spirometry results as well as results obtained over time and gives an overview of previously published reference equations...
  5. ncbi Pediatric lung transplantation for cystic fibrosis
    Theodore G Liou
    Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA
    Transplantation 86:636-7. 2008
    ..The US Lung Allocation Score has changed patient selection for lung transplantation but confounds the analysis of survival outcomes. A prospective trial is needed to resolve clinical equipoise and explore quality-of-life effects...
  6. ncbi Lung transplantation for cystic fibrosis
    Theodore G Liou
    Department of Internal Medicine, University of Utah, Salt Lake City, Utah 84132, USA
    Curr Opin Pulm Med 12:459-63. 2006
    ..To examine recent publications on lung transplantation for cystic fibrosis for changes in surgical techniques, selection criteria of patients, and impact on quality of life...
  7. ncbi Lung transplantation and survival in children with cystic fibrosis
    Theodore G Liou
    Department of Internal Medicine, University of Utah, Salt Lake City, USA
    N Engl J Med 357:2143-52. 2007
    ..The effects of lung transplantation on the survival and quality of life in children with cystic fibrosis are uncertain...
  8. ncbi Use of lung transplantation survival models to refine patient selection in cystic fibrosis
    Theodore G Liou
    Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Am J Respir Crit Care Med 171:1053-9. 2005
    ..Adult patients with low 5-year predicted survival without B. cepacia infection should receive priority for lung transplantation...
  9. ncbi Year-to-year changes in lung function in individuals with cystic fibrosis
    Theodore G Liou
    University of Utah, 26 North 1900 East, Salt Lake City, UT 84132 4701, USA
    J Cyst Fibros 9:250-6. 2010
    ..We examined the year-to-year change in FEV(1) for individuals and the overall cystic fibrosis population to better understand how individual trends may differ from population trends...
  10. ncbi Selection of patients with cystic fibrosis for lung transplantation
    Theodore G Liou
    Intermountain Cystic Fibrosis Center, Department of Internal Medicine, Division of Respiratory Critical Care and Occupational Pulmonary Medicine, University of Utah, Salt Lake City 84132, USA
    Curr Opin Pulm Med 8:535-41. 2002
    ..However, judicious use of the survival model to select patients for transplantation is likely to improve survival outcomes...
  11. ncbi Influenza vaccination coverage level at a cystic fibrosis center
    Bruce C Marshall
    Intermountain Cystic Fibrosis Center, Salt Lake City, Utah, USA
    Pediatrics 109:E80-0. 2002
    ..Annual vaccination is the most effective means to prevent or attenuate this illness. The vaccine is recommended for patients with cystic fibrosis (CF) older than 6 months, but the degree of adherence with this recommendation is unknown...
  12. ncbi Lung transplantation for cystic fibrosis
    Frederick R Adler
    Department of Mathematics, University of Utah, Salt Lake City, Utah 84112, USA
    Proc Am Thorac Soc 6:619-33. 2009
    ..Finally, the conference members carefully considered how efforts to improve outcomes for lung transplantation for CF lung disease might best be studied. This Roundtable seeks to communicate the substance of our discussions...
  13. ncbi Increasing pneumococcal vaccination rates among adults with cystic fibrosis
    David C Young
    Intermountain Cystic Fibrosis Adult Center, Salt Lake City, UT, USA
    Am J Health Syst Pharm 61:1490-3. 2004
  14. ncbi Toxicity effects of short term diesel exhaust particles exposure to human small airway epithelial cells (SAECs) and human lung carcinoma epithelial cells (A549)
    Mingjie Tang
    Department of Biological Engineering, Utah State University, Logan, UT, USA
    Toxicol Lett 215:181-92. 2012
    ..Cytokine and chemokine production measured by multiplex ELISA demonstrated DEP-induced inflammatory responses in both cell types...
  15. ncbi Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry
    Lynette M Brown
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT 84157 7000, USA
    Chest 140:19-26. 2011
    ..Despite the emergence of effective therapy, PAH is commonly at an advanced stage when recognized. Factors associated with a prolonged symptomatic period before the recognition of PAH have not been fully evaluated...
  16. ncbi Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation
    Patrick A Flume
    Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
    Chest 142:718-24. 2012
    ....
  17. ncbi Correction: Lung transplantation and survival in children with cystic fibrosis
    Theodore G Liou
    N Engl J Med 359:536. 2008
  18. ncbi Testing lung function decline to time lung transplantation
    Theodore G Liou
    Chest 128:472-3; author reply 473-4. 2005
  19. ncbi A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection
    George Z Retsch-Bogart
    Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7220, USA
    Pediatr Pulmonol 43:47-58. 2008
    ..Aztreonam lysine for inhalation (AZLI) is being developed for treatment of CF patients with Pseudomonas aeruginosa airway infection...
  20. ncbi Design of the REVEAL registry for US patients with pulmonary arterial hypertension
    Michael D McGoon
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 83:923-31. 2008
    ..REVEAL will be the richest source of data on patients with World Health Organization group I PAH...